Profit vs. Public Good: Bombay High Court Upholds Landmark Ban on For-Profit Medical Colleges

MUMBAI — In a decision that reinforces the traditional view of medicine as a service rather than a commodity, the Bombay High Court has officially upheld a National Medical Commission (NMC) regulation mandating that only “not-for-profit” entities can establish medical colleges in India. The ruling, delivered on January 28, 2026, by Justices Sandipkumar C. More and Abasaheb D. Shinde, dismissed a legal challenge from a private corporation that had already invested ₹355 crore in infrastructure. By affirming Regulation 6(g) of the 2023 Establishment of Medical Institutions Regulations, the court has signaled a firm judicial stance against the commercialization of medical education at a time when India is rapidly expanding its healthcare training capacity.

The Core Conflict: Education or Enterprise?

The legal battle began when a private limited company sought to launch a 150-seat MBBS college in Maharashtra. Despite securing initial state approvals and an “Essentiality Certificate” in late 2024, the NMC’s Undergraduate Medical Assessment and Rating Board (UG-MARB) rejected the application in January 2025. The rejection was based on the 2023 rule which restricted eligibility to Section 8 (not-for-profit) companies.

The petitioner argued that the NMC had exceeded its powers under the National Medical Commission Act, 2019, and claimed the rule violated constitutional rights to equality and the freedom to practice a profession or business. However, the High Court remained unmoved.

“If private companies meant for making profit only are allowed to start medical colleges, they will definitely use such colleges as commercial activities, frustrating the object of imparting knowledge to aspirants,” the Bench observed.

The court further noted that allowing for-profit entities could lead to exorbitant fee hikes, effectively making medical education a “monopoly of wealthy persons” and excluding talented students from less privileged backgrounds.

The Statistical Surge: Quantity vs. Quality

This ruling arrives during a period of unprecedented growth for Indian medical education. As of late 2025, India boasts over 137,600 MBBS positions across 816 colleges—a staggering leap from the 51,000 seats available in 2014.

However, this “seat explosion” has brought significant growing pains. Data from the NMC and the Indian Medical Association (IMA) suggest that nearly 50% of India’s 700+ existing colleges suffer from acute faculty shortages.

Dr. Sharad Kumar Agarwal, National President of the IMA, has frequently warned that rapid expansion without strict regulatory oversight risks “quality erosion.” The High Court’s decision is seen by many health advocates as a necessary brake on a system that might otherwise prioritize filling seats over producing competent, ethical physicians.

A Regulatory Tug-of-War

The High Court’s decision has created a complex legal landscape due to a recent “policy pivot” by the NMC itself. Just weeks before the ruling, NMC Chairman Dr. Abhijat Chandrakant Sheth announced that the commission would allow for-profit firms to establish colleges under Public-Private Partnership (PPP) models.

The Two Schools of Thought

Dr. S. Sacchidanand, former Vice-Chancellor of Rajiv Gandhi University of Health Sciences, argues that infrastructure gaps—such as missing laboratories or teaching hospitals—are often glossed over in profit-driven models. Conversely, proponents of for-profit models, including some members of NITI Aayog, suggest that under strict government oversight, corporate efficiency could actually lower costs through insurance-linked models and better resource management.

What This Means for Students and Patients

For the average Indian citizen and aspiring medical student, the ruling offers a mix of protection and uncertainty.

1. Fee Stability: By upholding the non-profit mandate, the court aims to curb the “commercialization” that leads to multi-million rupee tuition fees, ensuring that merit—not just bank balance—determines who becomes a doctor.

2. Standard of Care: For patients, the ruling emphasizes that teaching hospitals must prioritize public service. Under a non-profit mandate, the clinical experience for students is often tied to serving the general public, rather than catering exclusively to an elite “medical tourism” clientele.

3. The “Doctor Crunch”: While the ruling ensures integrity, critics worry it might slow the pace of college creation in underserved regions where state funding is scarce and non-profit capital is hard to come by.

The Road Ahead: Future Implications

The Bombay High Court’s decision specifically addresses the 2023 framework, but the NMC’s newer moves toward PPP models suggest that the door for private investment is not entirely closed—it is simply being fitted with a more rigorous frame.

The challenge for the Indian government in 2026 remains the “Rural-Urban Divide.” Currently, 65% of medical colleges are concentrated in urban areas, leaving rural populations with minimal access to the surge in new doctors. Whether the non-profit rule will foster a new generation of service-minded physicians or lead to a bottleneck in infrastructure remains the subject of intense debate among policymakers.

As the NMC continues to monitor colleges—having already withdrawn recognition from over 40 institutions in the last year for norm violations—the message from the judiciary is clear: In the pursuit of health, the ledger must always come second to the life.

References

• https://medicaldialogues.in/news/education/medical-colleges/medical-colleges-must-not-be-profit-driven-bombay-hc-upholds-nmcs-earlier-non-profit-rule-164623

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.